MDT

86.5

+0.42%↑

115.44

+0.79%↑

VEEV

173.86

+0.6%↑

HQY

84.6

+1.48%↑

PHR.US

8.34

-0.6%↓

MDT

86.5

+0.42%↑

115.44

+0.79%↑

VEEV

173.86

+0.6%↑

HQY

84.6

+1.48%↑

PHR.US

8.34

-0.6%↓

MDT

86.5

+0.42%↑

115.44

+0.79%↑

VEEV

173.86

+0.6%↑

HQY

84.6

+1.48%↑

PHR.US

8.34

-0.6%↓

MDT

86.5

+0.42%↑

115.44

+0.79%↑

VEEV

173.86

+0.6%↑

HQY

84.6

+1.48%↑

PHR.US

8.34

-0.6%↓

MDT

86.5

+0.42%↑

115.44

+0.79%↑

VEEV

173.86

+0.6%↑

HQY

84.6

+1.48%↑

PHR.US

8.34

-0.6%↓

Начало・Списък с акции・Anavex Life Sciences Corp

Anavex Life Sciences Corp

Отворен

СекторЗдравеопазване

2.99 -3.86

Купи Продай

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

2.94

Максимум

3.02

Ключови измерители
By Trading Economics
Приходи	4.1M -5.7M
Служители	34
EBITDA	3.1M -6.8M

Препоръки
By TipRanks
Препоръки	Купи
12-месечна прогноза	+568.9% upside

Дивиденти
By Dow Jones
Следващи печалби	12.05.2026 г.

Пазарни показатели
By TradingEconomics
Пазарна капитализация	-127M 261M
Предишно отваряне	6.85
Предишно затваряне	2.99

Настроения в новините

By Acuity

50%

166 / 349 Класиране в Healthcare

Техническа оценка

By Trading Central

Увереност

Very Strong Bearish Evidence

8.275 / 9.312 Подкрепа & съпротива

Anavex Life Sciences Corp Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

2.04.2026 г., 17:11 ч. UTC

Значими двигатели на пазара

Значими събития в новините

Home Depot Shares Hit 52-Week Low as Iran War Threatens Housing Rebound

2.04.2026 г., 17:10 ч. UTC

Значими събития в новините

ECB's Next Move Likely a Rate Rise, But Timing Unclear Amid Iran War, Villeroy Says

3.04.2026 г., 00:00 ч. UTC

Значими събития в новините

How Insulated Is the U.S. Economy From the Iran War? -- WSJ

2.04.2026 г., 23:47 ч. UTC

Пазарно говорене

Значими събития в новините

Nikkei Might Rise After Thursday's Selloffs -- Market Talk

2.04.2026 г., 21:05 ч. UTC

Придобивния, сливания и поглъщания

Starbucks: Under the Terms of the Agreement, Funds Managed by Boyu Cap Now Hold a 60% Stake in Starbucks China Retail Ops >SBUX

2.04.2026 г., 21:05 ч. UTC

Придобивния, сливания и поглъщания

Starbucks: Retains 40% Ownership Interest and Continues to Own and License the Brand and Intellectual Property to JV >SBUX

2.04.2026 г., 21:05 ч. UTC

Придобивния, сливания и поглъщания

Starbucks: Joint Venture Is Designed to Enhance Starbucks Ability to Expand Footprint, Deepen Local Relevance >SBUX

2.04.2026 г., 21:05 ч. UTC

Придобивния, сливания и поглъщания

Starbucks and Boyu Cap: Finalize Joint Venture to Accelerate Long-Term Growth in China

2.04.2026 г., 21:01 ч. UTC

Значими събития в новините

Investors Waver after Trump Speech on Iran, Ending Two-Day Surge in Stocks -- WSJ

2.04.2026 г., 20:59 ч. UTC

Придобивния, сливания и поглъщания

Starbucks and Boyu Capital Finalize China JV

2.04.2026 г., 20:50 ч. UTC

Пазарно говорене

Basic Materials Roundup: Market Talk

2.04.2026 г., 20:50 ч. UTC

Пазарно говорене

Health Care Roundup: Market Talk

2.04.2026 г., 20:41 ч. UTC

Печалби

These Stocks Are Today's Movers: Tesla, Globalstar, Blue Owl, United Airlines, Carnival, Lumentum, and More -- Barrons.com

2.04.2026 г., 20:32 ч. UTC

Пазарно говорене

Higher Gas Prices Intensify K-Shaped Economy -- Market Talk

2.04.2026 г., 20:30 ч. UTC

Придобивния, сливания и поглъщания

SBA Communications Stock Jumps on Report of Sale Talks -- Barrons.com

2.04.2026 г., 20:09 ч. UTC

Пазарно говорене

Eli Lilly On More Equal Footing With Rival With Weight-Loss Pill -- Market Talk

2.04.2026 г., 20:01 ч. UTC

Придобивния, сливания и поглъщания

SBA Communications Stock Jumps on Report of Sale Talks -- Barrons.com

2.04.2026 г., 19:46 ч. UTC

Пазарно говорене

Is Oil the New GameStop? -- Market Talk

2.04.2026 г., 19:35 ч. UTC

Пазарно говорене

U.S. Natural Gas Falls As Storage Injection Season Gets Under Way -- Market Talk

2.04.2026 г., 19:29 ч. UTC

Придобивния, сливания и поглъщания

SBA Communications Stock Jumps on Report of Sale Talks -- Barrons.com

2.04.2026 г., 19:24 ч. UTC

Пазарно говорене

Значими събития в новините

Oil Futures Jump Ahead of Long Weekend -- Market Talk

2.04.2026 г., 19:20 ч. UTC

Пазарно говорене

Nike Has Yet to Show That a Turnaround is on Horizon -- Market Talk

2.04.2026 г., 19:01 ч. UTC

Придобивния, сливания и поглъщания

Union Pacific: ATDA Agreement to Guarantee Jobs for Life for Union Employees After Norfolk Southern Deal

2.04.2026 г., 19:00 ч. UTC

Придобивния, сливания и поглъщания

Union Pacific: Agreement Reached With American Train Dispatchers Association

2.04.2026 г., 18:24 ч. UTC

Придобивния, сливания и поглъщания

Globalstar Stock Rises on Amazon Deal Report. Why Apple Could Scuttle the Launch. -- Barrons.com

2.04.2026 г., 17:44 ч. UTC

Пазарно говорене

Значими събития в новините

Oil Supply Squeeze Puts Refiners in a Quandary -- Market Talk

2.04.2026 г., 17:32 ч. UTC

Значими събития в новините

Amazon to Boost Fuel Surcharges on Third-Party Sellers as Costs Rise -- Barrons.com

2.04.2026 г., 17:26 ч. UTC

Печалби

These Stocks Are Today's Movers: Tesla, Globalstar, Blue Owl, United Airlines, Carnival, Lumentum, and More -- Barrons.com

2.04.2026 г., 17:17 ч. UTC

Пазарно говорене

Shares of Canadian Exports Heading to U.S. Continues to Slide -- Market Talk

2.04.2026 г., 17:09 ч. UTC

Пазарно говорене

Значими събития в новините

Oil Holds Gains After Trump Speech Disappointed Market -- Market Talk

Сравнение с други в отрасъла

Ценова промяна

Anavex Life Sciences Corp Прогноза

Ценова цел

By TipRanks

568.9% нагоре

12-месечна прогноза

Среден 20 USD 568.9%

Висок 20 USD

Нисък 20 USD

Според 1 анализатори от Wall Street, предложили 12-месечна ценова цел за Anavex Life Sciences Corp през последните три месеца.

Консенсусна оценка

By TipRanks

Купи

1 ratings

Купи

Задържане

Продай

Според 1 анализатори, дали борсови рейтинги на Anavex Life Sciences Corp през последните 3 месеца.

Техническа оценка

By Trading Central

8.275 / 9.312Подкрепа & съпротива

Recent bearish events outweigh bullish events.

Recent bullish events outweigh bearish events.

The bullish and bearish events are balanced.

Настроение

By Acuity

166 / 349 Класиране в Здравеопазване

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

Относно Anavex Life Sciences Corp

Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of therapeutics for the treatment of central nervous system diseases. Its lead product candidate is ANAVEX 2-73 for the treatment of Alzheimer's disease and Parkinson's disease, as well as other central nervous system diseases, including rare diseases, such as Rett syndrome, a rare severe neurological monogenic disorder; and infantile spasms, Fragile X syndrome, and Angelman syndrome. The company's drug candidate also comprises ANAVEX 3-71, which is in clinical trial for the treatment of schizophrenia, frontotemporal dementia, and Alzheimer's disease. Its preclinical drug candidates include ANAVEX 1-41 for the treatment of depression, stroke, and neurogenerative disease; ANAVEX 1066 for the potential treatment of neuropathic and visceral pain; and ANAVEX 1037 to treat prostate and pancreatic cancer. The company was incorporated in 2004 and is headquartered in New York, New York.